SCHEMBL4895342

SCHEMBL4895342

CCN(Sc1ccc(Oc2ccc(F)c(C)c2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 5/20 0.36
MAPT P10636 1/20 0.35
TP53 P04637 3/20 0.35
HTT P42858 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
P2RX3 P56373 1/20 0.35
CYP2C9 P11712 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905798 0.92 ALDH1A1 (0.44) TSHRALDH1A1LMNAMAPTHTT
SCHEMBL4899894 0.91 LMNA (0.43) ALDH1A1LMNATP53HTTL3MBTL1
SCHEMBL4904866 0.91 ALDH1A1 (0.43) TSHRALDH1A1LMNAMAPTHTT
SCHEMBL5930735 0.90 TSHR (0.36) TSHRALDH1A1LMNAHTTMEN1
SCHEMBL4906682 0.89 ALDH1A1 (0.48) TSHRALDH1A1LMNAMAPTTP53
SCHEMBL4902853 0.89 ALDH1A1 (0.45) TSHRALDH1A1LMNAMAPTHTT
SCHEMBL4904025 0.89 ALDH1A1 (0.45) TSHRALDH1A1LMNAMAPTTP53
SCHEMBL4906314 0.88 ALDH1A1 (0.44) TSHRALDH1A1LMNAMAPTHTT
SCHEMBL4902656 0.88 LMNA (0.44) TSHRALDH1A1LMNAMAPTHTT
SCHEMBL4906561 0.88 ALDH1A1 (0.44) TSHRALDH1A1LMNATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TSHR 412/4885ALDH1A1 2664/4885LMNA 317/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TSHR 400/4885ALDH1A1 2956/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.